Zeliang Ma, MD

Mayo Clinic Rochester

Rochester, MN

M.D./Ph.D. (2019.9-Present)
Radiation Oncology, Tsinghua University Peking Union Medical College
M.B. (2014.9-2019.6) equivalent to M.D. in the US
Clinical Medicine, Outstanding Graduate, Sun Yat-sen University

Fellow (2022.9-Present)
Radiation Oncology, Tsinghua University Peking Union Medical College
Resident (2019.9-2022.8)
Internal Medicine & Oncology, Tsinghua University Peking Union Medical College

Visiting Research Fellow (2023.10-Present)
Mayo Clinic, USA

https://scholar.google.com/citations?user=2MMcJokAAAAJ&hl=zh-CN

Disclosures:

Presentations

Sep 30

347 - Differential Prognostic Impact of Distant and Locoregional Recurrence on Survival in Surgically Resected Pathologic N2 NSCLC: Multicenter Dynamic Prediction with Landmark Model

04:10pm - 04:20pm PT

Sep 28

2169 - Preoperative PET/CT Personalized Radiomics Index with Deep Learning to Predict the Benefit of Postoperative Radiotherapy in Patients with pN2 NSCLC: A Pilot Study

Hall F

02:30pm - 04:00pm PT

Sep 30

3675 - Deep Learning-Driven Preoperative CT-Radiomics Model for Predicting Postoperative Radiation Therapy Benefit in the Elderly with NSCLC: A Multicenter Study

Hall F

04:00pm - 05:00pm PT

Sep 28

2427 - Postoperative Radiotherapy in Surgically Resected Pathologic N2 Non-Small Cell Lung Cancer Post-Chemotherapy: A Multicenter Study

Hall F

04:45pm - 06:00pm PT